Overview

Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Oxymorphone Extended Release is effective and safe in treating chronic pain in patients with cancer or neuropathic pain.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Oxymorphone